Applied The Platelet Rich Fibrin in Chronic Periodontitis
- Conditions
- Chronic Periodontitis
- Interventions
- Device: Platelet Rich FibrinDevice: Conventional Flap Surgery
- Registration Number
- NCT02594605
- Lead Sponsor
- Ataturk University
- Brief Summary
Platelet rich fibrin is a second generation platelet concentration which contains various growth factors. The aim of this study is to evaluate the clinical and biochemical efficacy of PRF in subjects of chronic periodontitis in the operation of conventional periodontal flap.
- Detailed Description
PRF was developed in 2001 by Choukroun in France, it was the second generation fibrin adhesive, and was used to accelerate the soft and hard tissue healing. Many studies have shown beneficial effects of PRF on osteoconductive filler material in sinus lift operations, treatment of periodontal sulcus defect and treatment of furcation defects. Also PRF contains many growth factors. PRF accelerates periodontal regeneration through the gradually excreted growth factors and contributes to the bone regeneration. In this study, the investigators evaluated the effect of PRF on growth factors and its contribution to periodontal regeneration in subjects with chronic periodontitis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
- Patients with CP who had pocket depth ≤ 5 mm and at least two area (grouped as Control and PRF) with horizontal bone loss after Phase I therapy
- The subjects excluded in the study had history of systemic disease, were smokers, had allergy to any drug, had need for prophylaxis of antibiotic and had taken antibiotics at least 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Platelet Rich Fibrin Platelet Rich Fibrin Platelet Rich Fibrin was applied with conventional flap surgery for treatment of periodontal bone loss in test group. Conventional Flap Surgery Conventional Flap Surgery Platelet Rich Fibrin was not applied to control groups. Only conventional flap surgery was applied to control groups.
- Primary Outcome Measures
Name Time Method Levels of IGF-1, VEGF, BMP-2, FGF-2 on Weekly 4 weeks Change from baseline IGF-1, VEGF, BMP-2, FGF-2 levels of GCF at 1 month were measured by periopaper.
- Secondary Outcome Measures
Name Time Method Alteration of Clinical Attachment Level 6 month Change from baseline Clinical Attachment Levels at 6 months were measured with periodontal probe.
Alteration of Periodontal Pocket Depth 6 month Change from baseline Pocket Depth at 6 months were measured with periodontal probe.
Trial Locations
- Locations (1)
Alper KIZILDAĞ
🇹🇷Denizli, Turkey